APPLICATION
ANDA040296
TYPE
ANDA
ORIGINAL APPROVAL
1999-11-01
LATEST ACTION
2002-02-08
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
ESTROPIPATEDiscontinued
ESTROPIPATE 3MG · TABLET · ORAL
ESTROPIPATEDiscontinued
ESTROPIPATE 0.75MG · TABLET · ORAL
ESTROPIPATEDiscontinued
ESTROPIPATE 1.5MG · TABLET · ORAL
Approval history
2002-02-08Manufacturing (CMC) · Supplement 2AP
2001-10-02Manufacturing (CMC) · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.